Search Results 61-70 of 17210 for Albinism
Inclusion Criteria: Male and/or female. Age ≥ 18 years at the time of screening. For patients aged < 20 years and enrolled in Japan, a written informed ...
About this study. The purpose of this study is to assess the long-term tolerability and safety of oral nintedanib treatment in patients with Progressive ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.
Page 1.
Publications · Khoja IT, Peck DS, Gavrilov DK, McPheron MA, Oglesbee D, Bentz Pino G, Sapp KL, Schultz MJ, Studinski Jones AL, White AL, Tortorelli S, Matern D, ...
The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...
This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.